Another lawsuit against Janssen Pharmaceuticals and Bayer Healthcare over the companies’ misleading marketing of their blood-thinner Xarelto has been filed by a women in Illinois who suffered severe personal injuries after taking the drug. The suit claims that though the healthcare companies marketed the stroke-preventing drug as safe and effective, during clinical trials, Xarelto was found to cause increased gastro-intestinal bleeding and death among many patients. The suit also alleges that Xarelto, which hit the drug market in 2011, saw $582 million in sales that year, but profits were mostly due to its overstated effectiveness and understated associated risks. That following year, the drug reportedly caused over 2,000 serious adverse events, 151 of them resulting in death. Janssen Pharmaceuticals claimed in response to the suit that “…the benefit-risk profile of Xarelto remains favorable and consistent with the clinical trials,” but the increased number of lawsuits filed against the companies suggest otherwise.